Blockchain Registration Transaction Record

BioStem Technologies to Present at Prestigious TD Cowen Healthcare Conference

BioStem Technologies announces presentation at 46th Annual TD Cowen Healthcare Conference to showcase perinatal tissue-derived regenerative therapies and proprietary BioRetain® processing method.

This presentation represents a significant milestone for BioStem Technologies as it seeks to expand its influence in the regenerative medicine sector. For investors, this provides crucial insight into the company's strategic direction, technological advancements, and market positioning within the competitive wound care industry. For patients and healthcare providers, BioStem's continued progress in perinatal tissue-derived therapies could translate to more effective treatment options for chronic wounds and tissue regeneration, potentially improving recovery outcomes and quality of life. The company's participation in such a prominent industry conference signals growing recognition of their innovative approach to maintaining growth factors and preserving tissue structure through their proprietary BioRetain® method, which could accelerate adoption of their products across healthcare systems.